Heterocyclic compounds useful as Raf kinase inhibitors

Details for Australian Patent Application No. 2008273017 (hide)

Owner Biogen Idec MA Inc. Sunesis Pharmaceuticals, Inc.

Inventors Wynn, Thomas; Cossrow, Jennifer; Xin, Zhili; Tanaka, Hiroko; Ishchenko, Alexey; Vessels, Jeffrey; Lugovskoy, Alexey; Raimundo, Brian; Powell, Noel; Kumaravel, Gnanasambandam; Peng, Hairuo; Guan, Bing; Jones, John Howard

Agent Cullens

Pub. Number AU-A-2008273017

PCT Pub. Number WO2009/006404

Priority 60/947,319 29.06.07 US

Filing date 30 June 2008

Wipo publication date 8 January 2009

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/006404 Priority application(s): WO2009/006404

12 January 2012 Assignment before Grant

  Biogen Idec MA Inc.; Sunesis Pharmaceuticals, Inc. The application has been assigned to Millennium Pharmaceuticals, Inc.; Sunesis Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008273030-Methods for extraction and purification of components of biological samples

2008273002-Pyrimidine derivatives useful as Raf kinase inhibitors